Clinical Trials Directory

Trials / Completed

CompletedNCT01263847

Galactooligosaccharide (GOS) Supplementation and Calcium Absorption in Girls

The Effect of Galactooligosaccharide (GOS) Supplementation on Calcium Absorption and Retention in Female Adolescent Girls

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Purdue University · Academic / Other
Sex
Female
Age
10 Years – 12 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effects of galactooligosaccharide (GOS) supplementation on calcium absorption and and gut microbe profiles.

Detailed description

Galactooligosaccharides (GOS) have been shown to have positive effects on calcium absorption in animals and postmenopausal women. This study aims to see whether the addition of fiber in the form of GOS to a calcium-containing yogurt drink will increase calcium absorption compared to placebo in a group of girls near menarche. Secondary outcomes are to assess physical fitness and determine the relationship between physical fitness and calcium absorption in adolescent girls as well as assess changes in gut microbiota. During this three phase, randomized, controlled crossover study, participants will consume yogurt drinks supplemented with 0, 2.5 or 5 grams of GOS twice daily for three weeks. Following each three week period, participants will complete a weekend clinical visit to measure calcium absorption. Height, weight, bone density and geometry, calcium absorption, gut microbiota and physical fitness will be measured. Effects of this GOS fiber intervention may help elucidate a mechanism of action for improving bone health with fiber supplementation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGalactooligosaccharideZero, 5 or 10 g/day of galactooligosaccharide will be administered in two yogurt drinks containing about 300 mg total calcium each per day for three weeks. During a clinical visit following three weeks of consumption, zero, 2.5 or 5 g of galactooligosaccharide will be administered in the same yogurt with the addition of 15 mg Ca-44 (calcium chloride). Participants will be given one of the above yogurts at breakfast in addition to intravenously receiving 3.5 mg Ca-43 (calcium chloride) in 4 ml saline one hour after breakfast consumption.

Timeline

Start date
2009-06-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2010-12-21
Last updated
2018-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01263847. Inclusion in this directory is not an endorsement.